JP2005507372A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005507372A5 JP2005507372A5 JP2002591483A JP2002591483A JP2005507372A5 JP 2005507372 A5 JP2005507372 A5 JP 2005507372A5 JP 2002591483 A JP2002591483 A JP 2002591483A JP 2002591483 A JP2002591483 A JP 2002591483A JP 2005507372 A5 JP2005507372 A5 JP 2005507372A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- methyl
- ylidene
- benzamide
- diisopropyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101767A SE0101767D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
| PCT/SE2002/000946 WO2002094810A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005507372A JP2005507372A (ja) | 2005-03-17 |
| JP2005507372A5 true JP2005507372A5 (OSRAM) | 2005-12-22 |
Family
ID=20284170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002591483A Pending JP2005507372A (ja) | 2001-05-18 | 2002-05-16 | 4−(フェニル−ピペリジン−4−イリデン−メチル)−ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20040138259A1 (OSRAM) |
| EP (1) | EP1395574B1 (OSRAM) |
| JP (1) | JP2005507372A (OSRAM) |
| KR (1) | KR20030094423A (OSRAM) |
| CN (1) | CN1547579A (OSRAM) |
| AR (1) | AR033756A1 (OSRAM) |
| AT (1) | ATE287400T1 (OSRAM) |
| BG (1) | BG108328A (OSRAM) |
| BR (1) | BR0209667A (OSRAM) |
| CA (1) | CA2446331A1 (OSRAM) |
| CO (1) | CO5540304A2 (OSRAM) |
| CZ (1) | CZ20033087A3 (OSRAM) |
| DE (1) | DE60202679T2 (OSRAM) |
| EE (1) | EE200300543A (OSRAM) |
| HU (1) | HUP0401285A2 (OSRAM) |
| IL (1) | IL158695A0 (OSRAM) |
| IS (1) | IS7024A (OSRAM) |
| MX (1) | MXPA03010438A (OSRAM) |
| NO (1) | NO20035118D0 (OSRAM) |
| PL (1) | PL366389A1 (OSRAM) |
| RU (1) | RU2003131968A (OSRAM) |
| SE (1) | SE0101767D0 (OSRAM) |
| SK (1) | SK13932003A3 (OSRAM) |
| WO (1) | WO2002094810A1 (OSRAM) |
| ZA (1) | ZA200308635B (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CL2004000754A1 (es) * | 2003-04-11 | 2005-02-25 | Janssen Pharmaceutica Nv | Uso de compuestos derivados de 4-fenil-4-(1h-imidazol-2-il)piperidina, como agonistas delta-opioides no peptidicos, para preparar un medicamento util en prevenir o tratar trastornos del sistema nervioso central. |
| SE0301443D0 (sv) * | 2003-05-16 | 2003-05-16 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| EP1641757A1 (en) * | 2003-05-16 | 2006-04-05 | AstraZeneca AB | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| WO2005005478A2 (en) * | 2003-07-02 | 2005-01-20 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled opioid receptor; delta 1 (oprd1) |
| BRPI0415165A (pt) | 2003-10-01 | 2007-01-09 | Adolor Corp | composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| AU2007294968A1 (en) | 2006-09-12 | 2008-03-20 | Adolor Corporation | Use of N-containing spirocompounds for the enhancement of cognitive function |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2898339A (en) * | 1957-07-29 | 1959-08-04 | Wm S Merrell Co | N-substituted benzhydrol, benzhydryl, and benzhydrylidene piperidine |
| US4581171A (en) * | 1983-07-27 | 1986-04-08 | Janssen Pharmaceutica, N.V. | [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones useful for treating psychotropic disorders |
| US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
| US5140029A (en) * | 1989-01-09 | 1992-08-18 | Janssen Pharmaceutica N.V. | 2-aminopyrimidinone derivatives |
| US4939137A (en) * | 1989-06-28 | 1990-07-03 | Ortho Pharmaceutical Corporation | Ring-fused thienopyrimidinedione derivatives |
| US5683998A (en) * | 1991-04-23 | 1997-11-04 | Toray Industries, Inc. | Tricyclic triazolo derivatives, processes for producing the same and the uses of the same |
| US5574159A (en) * | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
| TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| US6436959B1 (en) * | 1998-12-23 | 2002-08-20 | Ortho-Mcneil Pharmaceutical, Inc. | 4-[aryl(piperidin-4-yl)]aminobenzamides |
| SE0001207D0 (sv) * | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
-
2001
- 2001-05-18 SE SE0101767A patent/SE0101767D0/xx unknown
-
2002
- 2002-05-16 DE DE60202679T patent/DE60202679T2/de not_active Expired - Fee Related
- 2002-05-16 IL IL15869502A patent/IL158695A0/xx unknown
- 2002-05-16 MX MXPA03010438A patent/MXPA03010438A/es unknown
- 2002-05-16 HU HU0401285A patent/HUP0401285A2/hu unknown
- 2002-05-16 KR KR10-2003-7014944A patent/KR20030094423A/ko not_active Withdrawn
- 2002-05-16 AT AT02733703T patent/ATE287400T1/de not_active IP Right Cessation
- 2002-05-16 PL PL02366389A patent/PL366389A1/xx not_active Application Discontinuation
- 2002-05-16 US US10/477,854 patent/US20040138259A1/en not_active Abandoned
- 2002-05-16 JP JP2002591483A patent/JP2005507372A/ja active Pending
- 2002-05-16 SK SK1393-2003A patent/SK13932003A3/sk unknown
- 2002-05-16 RU RU2003131968/04A patent/RU2003131968A/ru not_active Application Discontinuation
- 2002-05-16 CN CNA02810191XA patent/CN1547579A/zh active Pending
- 2002-05-16 CZ CZ20033087A patent/CZ20033087A3/cs unknown
- 2002-05-16 EP EP02733703A patent/EP1395574B1/en not_active Expired - Lifetime
- 2002-05-16 EE EEP200300543A patent/EE200300543A/xx unknown
- 2002-05-16 BR BR0209667-6A patent/BR0209667A/pt not_active Application Discontinuation
- 2002-05-16 CA CA002446331A patent/CA2446331A1/en not_active Abandoned
- 2002-05-16 AR ARP020101812A patent/AR033756A1/es not_active Application Discontinuation
- 2002-05-16 WO PCT/SE2002/000946 patent/WO2002094810A1/en not_active Ceased
-
2003
- 2003-11-05 ZA ZA200308635A patent/ZA200308635B/en unknown
- 2003-11-07 BG BG108328A patent/BG108328A/bg unknown
- 2003-11-11 IS IS7024A patent/IS7024A/is unknown
- 2003-11-12 CO CO03100160A patent/CO5540304A2/es not_active Application Discontinuation
- 2003-11-17 NO NO20035118A patent/NO20035118D0/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005508293A5 (OSRAM) | ||
| JP2005510457A5 (OSRAM) | ||
| JP2003529596A5 (OSRAM) | ||
| JP2005508292A5 (OSRAM) | ||
| RU2003131964A (ru) | Производные 4-(фенил-пиперазинил-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| RU2284995C2 (ru) | Замещенные производные 2-фениламиноимидазолинфенилкетона в качестве антагонистов ip | |
| JP2006524222A5 (OSRAM) | ||
| JP2006514942A5 (OSRAM) | ||
| WO2005037792A1 (fr) | Derives de n-``phenyl(piperidin-2-yl)methyl !benzamide, leur preparation et leur application en therapeutique | |
| JP2005505583A5 (OSRAM) | ||
| RU2002125495A (ru) | Гидроксифенил-пиперидин-4-илиден-метил-бензамидные производные для лечения боли | |
| RU2003131970A (ru) | Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| JP2005508858A5 (OSRAM) | ||
| JP2005507372A5 (OSRAM) | ||
| EP1246808A1 (de) | 1,2-diarylbenzimidazole zur behandlung von krankungen die mit einer microglia-aktivierung assoziiert sind | |
| JP2003529598A5 (OSRAM) | ||
| RU2324680C2 (ru) | Производные диарилметилиденпиперидина, их применение, способы и промежуточное соединение для их получения | |
| JP2005508289A5 (OSRAM) | ||
| JP2003529597A5 (OSRAM) | ||
| FI57933C (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva olefina arylketoner | |
| JPH09500895A (ja) | メチルグアニジン誘導体、その製造方法およびそれを含有する組成物 | |
| RU2326875C2 (ru) | Производные 4-(фенил-пиперазинил-метил)бензамида и их применение для лечения боли или желудочно-кишечных расстройств | |
| RU2003131968A (ru) | Производные 4-(фенил-пиперидин-4-илиден-метил)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств | |
| JP2005508290A5 (OSRAM) | ||
| ZA200308634B (en) | 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders. |